World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
31328
World Ranking
19754
National Ranking
720

Otto Visser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Otto Visser sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 419 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Otto Visser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Otto Visser sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Otto Visser is affiliated with VU University Medical Center in the Netherlands. Their research primarily covers the field of Medicine, with a significant focus on Oncology, Pathology and Forensic Medicine, Genetics, Hematology, and Public Health, Environmental and Occupational Health.

The scientist's work addresses multiple specialized topics within oncology and hematology. Key subjects include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Global Cancer Incidence and Screening
  • Multiple and Secondary Primary Cancers
  • Viral-associated Cancers and Disorders
  • Acute Myeloid Leukemia Research

Otto Visser has contributed to various publications across several journals. Frequent publication venues include:

  • Blood Cancer Journal
  • European Journal of Cancer
  • Leukemia
  • Blood
  • British Journal of Haematology

Notable recent papers featuring Otto Visser's involvement are:

  • "Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands" (2020), The Lancet Oncology
  • "Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities" (2021), Cancer
  • "The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands" (2020), Journal of Hematology & Oncology
  • "Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study" (2020), European Journal of Cancer
  • "Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study" (2022), Blood

The scientist collaborates frequently with several coauthors, including:

  • Avinash G. Dinmohamed
  • Marie José Kersten
  • Eduardus F. M. Posthuma
  • Pieternella J. Lugtenburg
  • Marcel Nijland

Best Publications

  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

    Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood

  • Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

    J. Ferlay;M. Colombet;I. Soerjomataram;T. Dyba

  • Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

    Roberta De Angelis;Milena Sant;Michel P Coleman;Silvia Francisci

  • International incidence of childhood cancer, 2001-10 a population-based registry study

    Eva Steliarova-Foucher;Murielle Colombet;Lynn A G Ries;Florencia Moreno

  • Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

    Milena Sant;Claudia Allemani;Carmen Tereanu;Roberta De Angelis

  • Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

    Gemma Gatta;Laura Botta;Silvia Rossi;Tiiu Aareleid

  • Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

    Michael Schaapveld;Berthe M.P. Aleman;Anna M. van Eggermond;Cécile P.M. Janus

  • Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.

    Avinash G Dinmohamed;Avinash G Dinmohamed;Otto Visser;Rob H A Verhoeven;Marieke W J Louwman

  • Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    C.A. Stiller;A. Trama;D. Serraino;S. Rossi

  • Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

    David Palma;Otto Visser;Frank J. Lagerwaard;Jose Belderbos

  • Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    Gemma Gatta;Riccardo Capocaccia;Laura Botta;Sandra Mallone

  • Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

    Milena Sant;Pamela Minicozzi;Morgane Mounier;Lesley A Anderson

  • Incidence of Cancer in the Netherlands 1998

    O. Visser;Jan Willem W. Coebergh;Sabine Siesling;J.A.A.M. van Dijck

  • Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands

    Johanna M. Meulepas;Cécile M. Ronckers;Anne M.J.B. Smets;Rutger A.J. Nievelstein

  • Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry

    Catharina M. Korse;Babs G. Taal;Marie-Louise F. van Velthuysen;Otto Visser

  • Gender differences in stage-adjusted bladder cancer survival.

    N. Aydin Mungan;Katja K.H. Aben;Mark P. Schoenberg;Otto Visser

  • Changing incidence and improved survival of gliomas

    Vincent K.Y. Ho;Jaap C. Reijneveld;Roelien H. Enting;Henri P. Bienfait

  • Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

    Abdulbaqi Al-toma;Otto J. Visser;Hyacintha M. van Roessel;B. Mary E. von Blomberg

  • Incidence, survival and prevalence of myeloid malignancies in Europe

    O. Visser;A. Trama;M. Maynadie;C. Stiller

  • Incidence of cancer in the Netherlands.

    O. Visser;J.W.W. Coebergh;L.J. Schouten;J.A.A.M. Dijck

Frequent Co-Authors

Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Jan Willem Coebergh
Jan Willem Coebergh Erasmus University Rotterdam
Chris J. J. Mulder
Chris J. J. Mulder Amsterdam UMC
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Franco Berrino
Franco Berrino Fondazione IRCCS Istituto Nazionale dei Tumori
Charles A. Stiller
Charles A. Stiller Public Health England
Diego Serraino
Diego Serraino University of Oxford
Eva Ardanaz
Eva Ardanaz Instituto de Salud Pública de Navarra

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering careers in Medicine or healthcare, there are diverse online pathways to expand your skills and credentials. Whether you wish to focus on clinical practice, healthcare administration, or a specialized sector, online programs offer flexible learning options to suit various interests and schedules.

If you are passionate about nutrition and health, the best online food science degree programs provide comprehensive education in food safety, metabolism, and diet planning. Those interested in healthcare leadership may consider cahme-accredited online Master of Healthcare Administration programs, which ensure quality and industry-recognized standards.

Registered nurses can advance their careers through online rn to bsn programs without clinicals, offering a streamlined route to a bachelor's degree. For nursing professionals aiming for the highest level of clinical practice, the shortest dnp programs provide an accelerated path to a Doctor of Nursing Practice.

Exploring these related online degrees can open new opportunities in medicine, healthcare administration, and beyond, with flexible formats supporting today’s busy learners.

Best Scientists Citing Otto Visser

Trending Scientists

Recently Published Articles